MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Fragile X-associated tremor/ataxia syndrome, Parkinson’s disease, and essential tremor subjects demonstrate distinct tremor characteristics using quantitative tremorography

    E. Robertson, D. Hall, G. Pal, B. Ouyang, Y. Liu, A. McAsey, A. Bery, C. Huml, B. Bernard, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)

    Objective: To compare Fragile X-associated tremor/ataxia syndrome (FXTAS), Parkinson disease (PD), essential tremor (ET) and controls using quantitative measures of tremor. Background: FXTAS, a progressive…
  • 2018 International Congress

    Alternating thalamic deep brain stimulation for Essential Tremor: A trial to reduce habituation

    M. Seier, A. Hiller, J. Quinn, C. Murchison, M. Brodsky, S. Anderson (Omaha, NE, USA)

    Objective: We propose a novel approach to the treatment paradigm for deep brain stimulation (DBS) programming in the ventral intermediate nucleus (VIM) for patients with…
  • 2018 International Congress

    Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease

    H. Jeong, S. Chung, J. Oh, J. Kim, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the relationship between the sub-regional pattern of striatal dopamine depletion and cognitive impairment in early-stage Parkinson’s disease (PD), and determine the effect…
  • 2018 International Congress

    Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model. Background: In PD, oxidative…
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    The development of an instrument for measuring Parkinson’s patient empowerment

    P. Viwattanakulvanid (Bangkok, Thailand)

    Objective: To develop a valid and reliable measurement scale of Parkinson’s patient empowerment index (PPEI). Background: Patient empowerment concept has been used as part of…
  • 2018 International Congress

    Change of Cognition Functions after Subthalamic Nucleus-Deep Brain Stimulationin in Parkinson’s Disease

    L. Wu, L. Chen (Guangzhou, China)

    Objective: To explore the changes of cognitive function in Parkinson disease (PD) patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN). Background: STN-DBS…
  • 2018 International Congress

    Adult neurogenesis is impaired in pink1-/- zebrafish (Danio rerio)

    S. Bandmann, M. Keatinge, M. Placzek, O. Bandmann (Sheffield, United Kingdom)

    Objective: To determine whether PINK1 deficiency impairs adult neurogenesis in a tractable vertebrate model of PINK1-related Parkinson's disease (PD). Background: PD is characterized by loss…
  • 2018 International Congress

    Mitochondrial phenotype related to the A30P alpha-synuclein mutation as a patient-derived cellular model of Parkinson’s disease

    B. Santos, P. Barbuti, P. Antony, J. Arias, A. Hummel, J. Schwamborn, R. Krüger (Belval, Luxembourg)

    Objective: Our study aims to perform detailed phenotyping of the A30P alpha-synuclein familial case of PD, allowing to identify underlying mechanisms of the disease that…
  • 2018 International Congress

    A review of modifiers of Parkinsonism in the Leucine-rich repeat kinase 2 (LRRK2) population

    J. Staisch (Portland, OR, USA)

    Objective: To review and examine the most current identified modifiers of Parkinsonism in the LRRK2 population. Background: LRRK2 is a protein with multiple domains and…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • An atypical and interesting feature of Parkinson´s disease
      • A Case of Pregabalin induced Parkinsonism
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley